Gilead Sciences Inc at TD Cowen Health Care Conference Transcript
Welcome and good afternoon everyone. Welcome again to TD Cowen's 44th Annual Healthcare Conference, Day 2. My name is Tyler Van Buren, Senior Biotech Analyst here. For our next session, very pleased to have a fireside chat with Gilead. And from Gilead, it's my pleasure to introduce Andy Dickinson, Chief Financial Officer. Andy, thank you very much for being here.
Thank you, for us all to be here again. Thanks for having us.
So before I get started, if you guys have questions, chime in or raise your hand and we'll do our best to get them asked. So to open, Andy, I wanted to start with Gilead's 2024 guidance and a high-level overview of the business. And perhaps you could elaborate on some of the assumptions behind the 5% year-over-year product sales growth,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
